Eric Murphy is the founder of Kinnate Biopharma. Kinnate Biopharma has raised $195M in total funding. Latest round: Series C.
Eric Murphy co-founded Kinnate Biopharma in 2018. Kinnate Biopharma was a San Francisco-based clinical-stage precision oncology company focused on developing small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The company was funded through venture capital and an IPO, raising a total of $195.0M across 3 funding rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library